Particle
.news
Healthcare
❯
Pharmaceutical Industry
Alzheimer's Disease Treatment
Monoclonal Antibodies
12 ARTICLES
last year
FDA Delays Approval of Eli Lilly's Alzheimer's Drug Donanemab